欧洲药品管理局人用药物委员会建议扩大Uplizna(inebilizumab)治疗适应症,将活动性IgG4相关疾病成人患者纳入治疗范围

美股速递
Sep 19

欧洲药品管理局人用药物委员会建议扩大Uplizna(inebilizumab)的治疗适应症,将活动性IgG4相关疾病成人患者纳入治疗范围。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10